| 000 | 01777 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250518035939.0 | ||
| 264 | 0 | _c20200731 | |
| 008 | 202007s 0 0 eng d | ||
| 022 | _a1873-2496 | ||
| 024 | 7 |
_a10.1016/j.urolonc.2019.04.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHutterer, Georg C | |
| 245 | 0 | 0 |
_aBioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation study. _h[electronic resource] |
| 260 |
_bUrologic oncology _c07 2019 |
||
| 300 |
_a510-518 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Validation Study | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aB7-H1 Antigen _xanalysis |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xmortality |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 |
_aKi-67 Antigen _xanalysis |
| 650 | 0 | 4 |
_aKidney _xpathology |
| 650 | 0 | 4 |
_aKidney Neoplasms _xmortality |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Grading |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aNephrectomy |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aSurvivin _xanalysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPosch, Florian | |
| 700 | 1 | _aBuser, Lorenz | |
| 700 | 1 | _aZigeuner, Richard | |
| 700 | 1 | _aMorshäuser, Laura | |
| 700 | 1 | _aOtto, Wolfgang | |
| 700 | 1 | _aWild, Peter J | |
| 700 | 1 | _aBurger, Maximilian | |
| 700 | 1 | _aMay, Matthias | |
| 700 | 1 | _aPichler, Martin | |
| 700 | 1 | _aBrookman-May, Sabine D | |
| 773 | 0 |
_tUrologic oncology _gvol. 37 _gno. 7 _gp. 510-518 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.urolonc.2019.04.004 _zAvailable from publisher's website |
| 999 |
_c29662987 _d29662987 |
||